Cargando…
Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome
BACKGROUND & AIMS: Hepatobiliary phase (HBP) images can discriminate between benign and malignant liver lesions, but it is unclear if this approach can be used in patients with Budd-Chiari syndrome (BCS). Thus, we aimed to assess the diagnostic utility of HBP images in patients with BCS. METHODS...
Autores principales: | Van Wettere, Morgane, Paulatto, Luisa, Raynaud, Lucas, Bruno, Onorina, Payancé, Audrey, Plessier, Aurélie, Rautou, Pierre-Emmanuel, Paradis, Valérie, Cazals-Hatem, Dominique, Valla, Dominique, Vilgrain, Valérie, Ronot, Maxime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232085/ https://www.ncbi.nlm.nih.gov/pubmed/32435753 http://dx.doi.org/10.1016/j.jhepr.2020.100097 |
Ejemplares similares
-
Management of splanchnic vein thrombosis
por: Elkrief, Laure, et al.
Publicado: (2023) -
Behcet’s disease in budd-chiari syndrome
por: Desbois, Anne Claire, et al.
Publicado: (2014) -
Hepatic venous pressure gradient in sinusoidal obstruction syndrome: diagnostic value and link with histological lesions
por: Gressens, Simon B., et al.
Publicado: (2022) -
Small hepatic veins Budd–Chiari syndrome
por: Riggio, Oliviero, et al.
Publicado: (2013) -
Contrast‐enhanced CT and liver surface nodularity for the diagnosis of porto‐sinusoidal vascular disorder: A case‐control study
por: Valainathan, Shantha Ram, et al.
Publicado: (2022)